Schedule 13D ownership disclosure
Lineage Cell Therapeutics Inc
Common shares · CUSIP: 53566P109
Event date: 2025-11-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BROADWOOD PARTNERS, L.P.Reported CIK 0001278386
Shares: 57,455,729.00 · Class: 23.0%
- BROADWOOD CAPITAL, INC.Reported CIK 0001278387
Shares: 57,455,729.00 · Class: 23.0%
- NEAL C. BRADSHERReported CIK 0001278388
Shares: 57,848,357.00 · Class: 23.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-007051
- Form type
- SCHEDULE 13D/A
- Filer
- BROADWOOD PARTNERS, L.P.
- CIK
- CIK 1278386
- Filed
- Nov 14, 2025
- Reporting period
- Nov 12, 2025
- Description
- Schedule 13D beneficial ownership